Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12841999 | 0.77 | ALDH1A1 (0.53) | ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1 | |
| SCHEMBL4336677 | 0.77 | ALDH1A1 (0.58) | ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1 | |
| SCHEMBL13335390 | 0.77 | KDM4E (0.30) | ALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL12431236 | 0.72 | ALDH1A1 (0.67) | ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1 | |
| SCHEMBL14041411 | 0.72 | ALDH1A1 (0.57) | ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1 | |
| SCHEMBL1824398 | 0.71 | ALDH1A1 (0.56) | ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1 | |
| SCHEMBL12432242 | 0.69 | ALDH1A1 (0.68) | ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1 | |
| SCHEMBL10078608 | 0.68 | ALDH1A1 (0.57) | ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1 | |
| SCHEMBL10078611 | 0.67 | ALDH1A1 (0.55) | ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1 | |
| SCHEMBL4336648 | 0.67 | ALDH1A1 (0.90) | ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100119462-A1 | UV-FILTER COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100119462-A1 | UV-FILTER COMPOUNDS | ERCC4, ERCC5, ERCC1 | ALDH1A1 189/4885KDM4E 1538/4885SMN1; SMN2 4281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.